SCOPUS 정보 검색 플랫폼

Biological Psychiatry

Volumn 63, Issue 1, 2008, Pages

Mifepristone in Psychotic Depression?

(2) Carroll, Bernard J a Rubin, Robert T b

a Pacific Behavioral Research Foundation (United States)

b VA GREATER LOS ANGELES HEALTHCARE SYSTEM (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIFEPRISTONE; PLACEBO;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEPRESSIVE PSYCHOSIS; DRUG EFFICACY; DRUG MECHANISM; ELECTROCONVULSIVE THERAPY; HUMAN; LETTER; MAJOR DEPRESSION; PRIORITY JOURNAL; PSYCHOSIS; TREATMENT DURATION;

DEPRESSIVE DISORDER, MAJOR; HORMONE ANTAGONISTS; HUMANS; MIFEPRISTONE; PSYCHOTIC DISORDERS;

EID: 36849096165 PISSN: 00063223 EISSN: None Source Type: Journal
DOI: 10.1016/j.biopsych.2007.03.032 Document Type: Letter

Times cited : (14)

References (6)

1
- 33750483274
- Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression
- DeBattista C., Belanoff J., Glass S., Khan A., Horne R.L., Blasey C., et al. Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression. Biol Psychiatry 60 (2006) 1343-1349
- (2006) Biol Psychiatry , vol.60 , pp. 1343-1349
- DeBattista, C.¹ Belanoff, J.² Glass, S.³ Khan, A.⁴ Horne, R.L.⁵ Blasey, C.⁶

2
- 33244489555
- Clinical and biological effects of mifepristone treatment for psychotic depression
- Flores B.H., Kenna H., Keller J., Solvason H.B., and Schatzberg A.F. Clinical and biological effects of mifepristone treatment for psychotic depression. Neuropsychopharmacology 31 (2006) 628-636
- (2006) Neuropsychopharmacology , vol.31 , pp. 628-636
- Flores, B.H.¹ Kenna, H.² Keller, J.³ Solvason, H.B.⁴ Schatzberg, A.F.⁵

3
- 0036752158
- An open label trial of C-1073 (mifepristone) for psychotic major depression
- Belanoff J.K., Rothschild A.J., Cassidy F., DeBattista C., Baulieu E.E., Schold C., and Schatzberg A.F. An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol Psychiatry 52 (2002) 386-392
- (2002) Biol Psychiatry , vol.52 , pp. 386-392
- Belanoff, J.K.¹ Rothschild, A.J.² Cassidy, F.³ DeBattista, C.⁴ Baulieu, E.E.⁵ Schold, C.⁶ Schatzberg, A.F.⁷

4
- 33751089294
- Is mifepristone useful in psychotic depression?
- Carroll B.J., and Rubin R.T. Is mifepristone useful in psychotic depression?. Neuropsychopharmacology 31 (2006) 2793-2794
- (2006) Neuropsychopharmacology , vol.31 , pp. 2793-2794
- Carroll, B.J.¹ Rubin, R.T.²

5
- 36849015611
- Corcept Therapeutics (2006a). Accessed August 25, 2006
- Corcept Therapeutics (2006a). Corcept therapeutics announces negative results from the first of three phase 3 studies evaluating CORLUX(R) for treating the psychotic features of psychotic major depression. Accessed August 25, 2006. http://biz.yahoo.com/prnews/060825/laf018.html?.v=61
- Corcept therapeutics announces negative results from the first of three phase 3 studies evaluating CORLUX(R) for treating the psychotic features of psychotic major depression

6
- 36849080100
- Corcept Therapeutics (2006b). Accessed September 29
- Corcept Therapeutics (2006b). Corcept therapeutics announces negative results from the second of three phase 3 studies evaluating CORLUX(R) for treating the psychotic features of psychotic major depression. Accessed September 29 (2006). http://biz.yahoo.com/prnews/060929/sff012.html?.v=76
- (2006) Corcept therapeutics announces negative results from the second of three phase 3 studies evaluating CORLUX(R) for treating the psychotic features of psychotic major depression

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.